Various methods and systems are provided for a set of devices for an imaging system. In one example, the set of devices includes a first device configured to obtain a first set of image data and a second device configured to obtain a second set of image data along at least one dimension. The first and second sets of data may be compiled to generate a field-of-view (FOV) preview.

A nerve stimulation system including a stimulation probe including a handle and a stimulation head at an end of the handle; a reference electrode; and a control system in communication with the stimulation probe and the reference electrode, the control system configured to generate an electrical stimulation signal that, when delivered to a skin surface of a patient using the stimulation probe, induces an activation potential in a plurality of nociceptors while remaining below a threshold that induces a muscle contractile response.

Systems, device, and methods for staging a pressure injury are provided which may include providing a series of questions to a clinician to answer based on a provided visualization of a pressure injury. The clinician may provide answers in a yes or no format, which may be displayed with the series of questions. A final assessment may be provided based on the series of questions and corresponding answers. The questions, answers, and assessment may be provided in a visual flowchart format along with recommendations to compare the visualization of the pressure injury with a medical definition.

A multispectral synchronized imaging system is provided. A multispectral light source of the system comprises: blue, green and red LEDs, and one or more non-visible light sources, each being independently addressable and configured to emit, in a sequence: at least visible white light, and non-visible light in one or more given non-visible frequency ranges. The system further comprises a camera and an optical filter arranged to filter light received at the camera, by: transmitting visible light from the LEDs; filter out non-visible light from the non-visible light sources; and otherwise transmit excited light emitted by a tissue sample excited by non-visible light. Images acquired by the camera are output to a display device. A control unit synchronizes acquisition of respective images at the camera for each of blue light, green light, visible white light, and excited light received at the camera, as reflected by the tissue sample.

The present technology relates to the field of medical monitoring, and, in particular, to non-contact detecting and monitoring of patient breathing. Systems, methods, and computer readable media are described for calculating a change in depth of a region of interest (ROI) on a patient. In some embodiments, the systems, methods, and/or computer readable media can identify steep changes in depths. For example, the systems, methods, and/or computer readable media can identify large, inaccurate changes in depths that can occur at edge regions of a patient. In these and other embodiments, the systems, methods, and/or computer readable media can adjust the identified steep changes in depth before determining one or more patient respiratory parameters.

Disclosed methodologies provide improved predictors of patient treatment adherence by using person-specific subjective experience and social-environmental factors. Methodologies combine emotion and data sciences. Advanced tools capture, measure, store, and analyze self-report of subjective experiences using digital applications and platforms. Patient-specific data is obtained regarding emotional or affective determinants and social determinants for generating a calculated composite score of the patient's probability of adherence or achievement relative to target outcomes, e.g. adherence to treatment plans, wellness activities, etc. for a subject individual. Internal/subjective factors are judged by self-report measures designed to validly judge tested factors based on a patient adjusting continuously-variable graphical interfaces to capture and measure subjective experiences. Emotional characteristics may include perception and intensity in each category of sickness versus wellness, stress, depression, anxiety, pain, and feelings about most recent health provider/staff interaction (with determined intensity for choices of Delighted, Satisfied, Meh, Disappointed, Frustrated). Emotional characteristics may be considered among health, and social characteristics in measuring potential obstacles to adherence.

Methods and systems are provided for evaluating injection sites on a body of a patient. The methods/systems may instruct a patient to place one or more capacitance sensors in contact with a potential injection site on the body of the patient. The methods/systems may also comprise using a processing circuit to receive data indicative of a capacitance of body tissue at the potential injection site, as measured by the one or more capacitance sensors. The methods/systems may also comprise generating, using the processing circuit, an indication of a level of pain that would be expected to be experienced by the patient from a potential injection at the potential injection site based on the received capacitance.

Systems and methods directed to the assessment of circulatory complications due to advancement of diabetes. Embodiments include an optical measurement device having a light source with one or more wavelengths and configured to illuminate an area of tissue, a detector configured to capture the light reflecting from one or more layers of the tissue at the one or more illumination wavelengths, a processor configured to compute, based on the detected signal of layer extracted circulatory data, one or more estimates of tissue vascular health, and a display or communication device (e.g., electronic data transfer) configured to store or report the tissue vascular health. In exemplary embodiments, the distribution of chromophores such as hemoglobin in different layers of skin is extracted using a combination of structured light in the visible and near-infrared regime.

Disclosed are techniques for identifying and displaying spatial relationships between a seed parcel and other parcels in a patient's brain. A method can include obtaining connectivity data characterizing, for each pair of parcels including a first parcel and a second parcel from a group of parcels, a connectivity metric measuring a relationship between the first and second parcels in the patient's brain, obtaining brain atlas data, identifying a seed parcel from the group of parcels, determining one or more other parcels in the group of parcels having a connectivity metric with the seed parcel that satisfies a threshold connectivity metric condition to provide at least one seed-connected parcel, and for the seed-connected parcel, providing the brain atlas data and an indication of a degree of the connectivity metric between the seed parcel and seed-connected parcel for display as an overlay on a visualization of the brain atlas data.

Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.